We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
-0.81%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
10 Year Est. Return
AUM
$147M
AUM Growth
-$239K
Cap. Flow
+$3.71M
Cap. Flow %
2.52%
Top 10 Hldgs %
31.07%
Holding
300
New
41
Increased
19
Reduced
68
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 14.78%
2 Consumer Discretionary 12.16%
3 Healthcare 11.4%
4 Industrials 11.16%
5 Financials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBH icon
126
KB Home
KBH
$3.59B
$290K 0.2%
+6,276
New +$319K
PAHC icon
127
Phibro Animal Health
PAHC
$1.39B
$290K 0.2%
22,744
+6,200
+37% +$87.9K
MRK icon
128
Merck
MRK
$318B
$290K 0.2%
2,821
-4,444
-61% -$479K
HEI icon
129
HEICO Corp
HEI
$51.4B
$290K 0.2%
1,788
VCYT icon
130
Veracyte
VCYT
$3.8B
$287K 0.2%
12,864
EXEL icon
131
Exelixis
EXEL
$13.4B
$284K 0.19%
+13,000
New +$272K
AMPH icon
132
Amphastar Pharmaceuticals
AMPH
$916M
$281K 0.19%
6,109
CARR icon
133
Carrier Global
CARR
$52.8B
$279K 0.19%
5,052
DVA icon
134
DaVita
DVA
$11.7B
$279K 0.19%
2,949
-344
-10% -$35.1K
AGS
135
DELISTED
PlayAGS
AGS
$278K 0.19%
42,567
+17,000
+66% +$114K
IR icon
136
Ingersoll Rand
IR
$33.7B
$271K 0.18%
4,251
NBIX icon
137
Neurocrine Biosciences
NBIX
$16.6B
$268K 0.18%
+2,381
New +$251K
CVLT icon
138
Commault Systems
CVLT
$5.61B
$263K 0.18%
3,886
MOH icon
139
Molina Healthcare
MOH
$10.3B
$262K 0.18%
800
-93
-10% -$29.3K
EHC icon
140
Encompass Health
EHC
$12.4B
$262K 0.18%
3,901
ADMA icon
141
ADMA Biologics
ADMA
$2.22B
$261K 0.18%
72,895
+12,462
+21% +$48K
BLKB icon
142
Blackbaud
BLKB
$2.08B
$260K 0.18%
+3,703
New +$273K
SMCI icon
143
Super Micro Computer
SMCI
$20.1B
$259K 0.18%
+9,460
New +$264K
SAIC icon
144
Saic
SAIC
$5.35B
$256K 0.17%
2,430
FHI icon
145
Federated Hermes
FHI
$4.72B
$256K 0.17%
7,549
CYTK icon
146
Cytokinetics
CYTK
$10.4B
$255K 0.17%
8,664
+720
+9% +$24K
WMK icon
147
Weis Markets
WMK
$1.86B
$253K 0.17%
4,022
AMRX icon
148
Amneal Pharmaceuticals
AMRX
$5.79B
$252K 0.17%
59,710
+15,230
+34% +$56.8K
ORCL icon
149
Oracle
ORCL
$423B
$252K 0.17%
2,376
-277
-10% -$32.1K
NEWR
150
DELISTED
New Relic, Inc.
NEWR
$245K 0.17%
2,866

Similar funds

Virtus Investment Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Virtus Investment Advisers held 300 positions worth $147M, down 0.16% from $147M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Virtus Investment Advisers's Q3 2023 filing shows 41 new, 19 increased, 68 reduced and 58 closed positions. Its largest new stake was PIMCO Enhanced Short Maturity Active ESG ETF: 110,000 shares worth $10.8M. The largest sale was iQIYI, an estimated $2.35M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Virtus Investment Advisers's largest Q3 2023 buy was PIMCO Enhanced Short Maturity Active ESG ETF: 110,000 shares worth $10.8M.
  • Virtus Investment Advisers added most to NVIDIA in Q3 2023, an estimated $1.07M increase.
  • Virtus Investment Advisers's biggest Q3 2023 reduction was iShares ESG Aware MSCI USA ETF, cutting an estimated $1.64M.
  • Virtus Investment Advisers fully exited iQIYI in Q3 2023, selling an estimated $2.35M.
  • Virtus Investment Advisers's ten largest holdings make up 31% of its $147M portfolio in Q3 2023.
  • Virtus Investment Advisers opened 41 new positions and closed 58 in Q3 2023.
  • Virtus Investment Advisers's portfolio value fell 0.16% quarter-over-quarter to $147M.

Based on Virtus Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.